Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda
Charles Drago Kato, Julius Nsubuga, Nixon Niyonzima, Annah Kitibwa, Enock Matovu, Emmanuel Othieno, Patrick Ssebugere, Amanda Agnes Tumwine, Monica Namayanja · 2023
Read Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda by Charles Drago Kato, Julius Nsubuga, Nixon Niyonzima, Annah Kitibwa, Enock Matovu, Emmanuel Othieno, Patrick Ssebugere, Amanda Agnes Tumwine, Monica Namayanja (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10701962.txt.
Description
Kato and coauthors compare blood marks in COVID patients in Uganda by illness grade. Each new virus needs a map of host response marks. Swelling marks may flag who will get very ill or die. They may also point to drug targets for care.
Blood samples split into no-sign, mild, and severe illness groups. Healthy adults gave a contrast set for all tests. Lab kits gauged swelling and chemical marks in plasma. Marks shifted a lot across the illness grades. Severe cases held the most skewed mark profiles. Some marks may help triage patients in low-resource clinics.
Catalog record
| CREATOR | Charles Drago Kato, Julius Nsubuga, Nixon Niyonzima, Annah Kitibwa, Enock Matovu, Emmanuel Othieno, Patrick Ssebugere, Amanda Agnes Tumwine, Monica Namayanja |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |